Your session is about to expire
← Back to Search
Smartphone App for Post-Surgery Care in Bladder Cancer
N/A
Recruiting
Led By Jeffery Montgomery, M.D.
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients undergoing a radical cystectomy with reconstruction through GU Oncology Clinic
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days post hospital discharge
Awards & highlights
Study Summary
This trial uses a smartphone app to help prevent readmissions after major cancer surgery, improving outcomes, reducing mortality, and saving costs.
Who is the study for?
This trial is for English-speaking bladder cancer patients at the University of Michigan who are undergoing radical cystectomy. Participants must have access to a smartphone or tablet with internet to use the CLEAR Care Companion app.Check my eligibility
What is being tested?
The study tests if a smartphone application, which tracks symptoms and provides educational content after major cancer surgery, can improve communication with doctors, patient satisfaction, and reduce hospital readmissions.See study design
What are the potential side effects?
Since this trial involves using an application rather than medication, traditional side effects are not expected. However, users may experience stress or frustration if technical issues arise while using the app.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am having bladder removal surgery with reconstruction.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 42 days post hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days post hospital discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Duration of engagement with application
Frequency of engagement with application
Patient Experience Survey -- Overall Care (all participants)
+2 moreSecondary outcome measures
Patient Experience Survey -- Application (all participants)
Patient Experience Survey -- Application (first 20 participants)
Readmission rate
Trial Design
1Treatment groups
Experimental Treatment
Group I: CLEAR CCExperimental Treatment1 Intervention
Patients use CLEAR CC application with Smartphone or Tablet
Find a Location
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
23,847 Total Patients Enrolled
Jeffery Montgomery, M.D.Principal InvestigatorUniversity of Michigan Rogel Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak English.I am having bladder removal surgery with reconstruction.
Research Study Groups:
This trial has the following groups:- Group 1: CLEAR CC
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities for newly enrolled participants to join this trial?
"Indeed, clinicaltrials.gov indicates that this medical experiment has been opened and is now recruiting participants since December 1st 2022. The last update to the study was November 8th 2022, with an aim of enrolling 250 patients at a single location."
Answered by AI
To what extent is this trial populated with participants?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which was first made public on December 1st 2022, is currently recruiting participants for the study. 250 participants are required to join from a single medical centre."
Answered by AI
Share this study with friends
Copy Link
Messenger